Zachary Cain

Statistics

Publications

Citations

449

H-Index

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Zachary Cain is an author at Bristol-Myers Squibb (United States) specializing in selective serotonin reuptake inhibitor treatment, molecular imaging, and pharmacy.

Publications per year

2004–2015

Publications

Conjugated Polymer Dots for Multiphoton Fluorescence Imaging

Changfeng Wu, Craig Szymanski, Zachary Cain et al. · Journal of the American Chemical Society · 2007 · 321 citations · Full text

Natural Sciences, Biomedical Engineering, Materials Science +17

History and Outlook for Farm Bill Conservation Programs

Zachary Cain, Stephen B. Lovejoy · AgEcon Search (University of Minnesota, USA) · 2004 · 66 citations · Full text

Public Affairs, Agricultural Economics, Environmental Policy +15

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Anita H. Clayton, Ross A. Baker, John J. Sheehan et al. · BMC Research Notes · 2014 · 28 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting

Nicholas J. Di Bella, Debajyoti Bhowmik, Menaka Bhor et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 22 citations

Medicine, Oncology, Pharmacology +12

Turning personal calendars into scheduling assistants

Jacob Bank, Zachary Cain, Yoav Shoham et al. · 2012 · 12 citations

Management, Computer Systems, Automation +13

1–5 of 5